Senior Director, Early Differentiation & Pipeline Strategy (EDAPS), Oncology

Bristol Myers Squibb seeks a Senior Director to lead medical strategy for early-stage hematology and oncology assets from candidate selection through clinical proof-of-concept. The role involves developing differentiated clinical strategies, managing medical evidence generation, and partnering with internal teams and external thought leaders to maximize asset potential.

Responsibilities

• Own medical strategy and accountability for subset of early hematology-oncology assets
• Develop integrated evidence plans and medical communications strategies for assigned compounds
• Serve as critical thought partner to global program leads and clinical development teams
• Lead advisory board planning and execution with external thought leaders and patient advocacy groups
• Collaborate across R&D, Medical, and Commercial functions to inform portfolio decisions and clinical differentiation

Requirements

• Advanced degree (MD, PharmD, or PhD)
• 8-10 years of clinical, medical, or pharmaceutical industry experience
• Therapeutic expertise in malignant hematology and/or oncology
• Proven ability to engage with thought leaders in early clinical settings
• Strong capability to manage multiple assets and priorities in matrixed environments
• Excellent scientific communication and stakeholder alignment skills

Compensation: $229,380 - $277,956